AZ sues Watson to stop copycat Crestor; Erbitux study raises KRAS questions;

@FiercePharma: NICE to be sidelined, minister confirms. Report | Follow @FiercePharma

> AstraZeneca has sued Watson Pharmaceuticals to block the launch of a generic version of Crestor, a cholesterol-lowering medicine and the company's top seller. Report

> Eli Lilly and Merck KGaA's Erbitux helped a group of cancer patients thought to be immune to the treatment in a study that contradicts earlier assumptions of the way the drug works in those with a genetic mutation. News

> The Australian Competition and Consumer Commission postponed its decision on whether to allow a bid by Aspen Pharmacare for Sigma Pharmaceuticals' generic drugs division. Item

> PhRMA says a new Puerto Rico law to tax offshore manufacturers will "dramatically hinder" biopharma companies. Article

> Attorneys general in Illinois, Oregon and California said on Tuesday that Bayer agreed to a $3.3 million settlement over misleading claims that the drugmaker's vitamins reduced men's risk of prostate cancer. News

> Abbott Laboratories sued generics maker Anchen Pharmaceuticals in federal court in Delaware for infringing a U.S. patent for the kidney drug Zemplar. Story

Biotech News

 @FierceBiotech: Analysts take on obesity drugs turns grim after lorcaserin CRL. Report | Follow @FierceBiotech

  @JohnCFierce: Rodman & Renshaw analyst Elemer Piros on the future of obesity drugs: "This whole space is pretty much dead." News | Follow @JohnCFierce

> Corengi tech could enlarge pool of trial subjects. Report

> Bonfiglio named president, CEO of Transdel. News 

> Myriad gains from Abbott testing deal. Story

> Index founds Mind-NRG with $13.8M investment. Article 

> PacBio raises $200M with IPO. News

Drug Delivery News

> Highland looks for partners for abuse-resistant prescriptions. Story 

> NCI rewards DNA/RNA nanomotor work with $2.5M. Item 

> 'Stapled peptides' still the talk of the town. Report 

> Chinese microneedle company wins Silver from WSJ. Story. Article

> Georgia Tech, Emory use NCI grants, nanoparticles to target cancers. News 

> DIY drug administration on rise. Story

Medical Devices News

> Edwards, Hospira, KCI discuss Q3 results. Story

> ExonHit backs out of $22.5M RedPath buyout. Item

> How safe are endoscopies? Report

> Boston Sci looks at more acquisitions as Asthmatx deal closes. Article 

> Can brain signals can control prosthetic arms? Story

> SpectraScience announces strategic restructuring. News 

And Finally... It could be selling season for pharmacy benefit managers, with Walgreen and Cigna rumored to be selling their PBM units. Report

Suggested Articles

With momentum building in Pfizer’s gene therapy programs, it has bought a building in North Carolina where it will consolidate clinical manufacturing.

Novo Nordisk had been hoping to show its Tresiba could top Sanofi’s Toujeo in a head-to-head showdown, but it didn't quite get there.

GlaxoSmithKline won an FDA panel recommendation for its over-the-counter nicotine spray—but the backing didn’t come easy.